Home

EXAMON Handelsges.m.b.H. sell "Gefitinib-GEFISA®"

Basic Information

1.2K
66
10
4.4(69)

Trade Type

Sell

Product Name

Gefitinib-GEFISA®

Specifications

  • Dosage Form: Oral film-coated tablet
  • Strength: 250 mg
  • Indication: First-line treatment of EGFR-mutation-positive non-small cell lung cancer (NSCLC)

Documents

CE
GMP
ISO
Filters:
Sort by:

    No comments available.

Matched Products & Services

B2B matches based on trade type, category, specifications & price range

Similar Products & Services

Products & Services related to what you're viewing

People Also Viewed

Other products & services viewed by people who looked at this product